today announces two poster presentations at the European Society for Medical Oncology (ESMO)'s European Lung Cancer Congress 2025 (ELCC 2025). The studies demonstrate how Volition's Nu.Q ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Morningstar brands and products Company Portfolio ...

The poster will be presented at the European Lung Cancer Congress (ELCC ... The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company's ...